YU52202A - Supstituisani benzoil-gvanidini, postupak za njihovu proizvodnju, njihova primena kao leka ili kao dijagnostičkog reagensa i medikament koji sadrži ova jedinjenja - Google Patents
Supstituisani benzoil-gvanidini, postupak za njihovu proizvodnju, njihova primena kao leka ili kao dijagnostičkog reagensa i medikament koji sadrži ova jedinjenjaInfo
- Publication number
- YU52202A YU52202A YU52202A YUP52202A YU52202A YU 52202 A YU52202 A YU 52202A YU 52202 A YU52202 A YU 52202A YU P52202 A YUP52202 A YU P52202A YU 52202 A YU52202 A YU 52202A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- medicament
- benzoylguanidines
- production
- diagnostic agent
- containing same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Surgery (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Pronalazak se odnosi na benzoil-gvanidine Formule I, u kojoj R2 je -Y-p-(C6H4)-R11, -Y-m-(C6H4)-R11 ili -Y-o-(C6H4)-R11; R11 je (C1C9)-heteroaril, koji je preko C ili N povezan i koji nije supstituisan ili je supstiituisan sa 1 do 3 supstituenata izabranih iz grupe koju sacinjavaju F, Cl, CF3 CH3, metoksi, hidroksi, amino, metilamino, dimetilamino i benzil; Y je kiseonik, -S- ili NR12; R12 je H ili (C1-C4)-alkil; R4 je F, Cl, Br, J ili C1C4-alkil; R1 i R3 koji imaju znacenja navedena u Zahtevima, su pogodni za koriscenje kao antiaritmijski lekovi sa kardioprotektivnom komponentom za profilaksu i lecenje infarkta kao i za lecenje angine pektoris. Oni isto tako preventivno inhibiraju patofizioloske procese vezane za pojavu oboljenja prouzrokovanih ishemijom, narocti pri pojavi srcanih aritmija prouzrokovanih ishemijom.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10001879A DE10001879A1 (de) | 2000-01-19 | 2000-01-19 | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
Publication Number | Publication Date |
---|---|
YU52202A true YU52202A (sh) | 2006-01-16 |
Family
ID=7627855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU52202A YU52202A (sh) | 2000-01-19 | 2001-01-08 | Supstituisani benzoil-gvanidini, postupak za njihovu proizvodnju, njihova primena kao leka ili kao dijagnostičkog reagensa i medikament koji sadrži ova jedinjenja |
Country Status (27)
Country | Link |
---|---|
US (1) | US6703411B2 (sh) |
EP (1) | EP1259481B1 (sh) |
JP (1) | JP4880849B2 (sh) |
KR (1) | KR100726701B1 (sh) |
CN (1) | CN1184196C (sh) |
AR (1) | AR027237A1 (sh) |
AT (1) | ATE530518T1 (sh) |
AU (1) | AU780466B2 (sh) |
BR (1) | BR0107660A (sh) |
CA (1) | CA2397531A1 (sh) |
CZ (1) | CZ20022465A3 (sh) |
DE (1) | DE10001879A1 (sh) |
EE (1) | EE200200381A (sh) |
HK (1) | HK1051853A1 (sh) |
HR (1) | HRP20020592A2 (sh) |
HU (1) | HUP0204095A3 (sh) |
IL (1) | IL150740A0 (sh) |
MX (1) | MXPA02006431A (sh) |
NO (1) | NO20023383L (sh) |
NZ (1) | NZ520213A (sh) |
PL (1) | PL356589A1 (sh) |
RU (1) | RU2267486C2 (sh) |
SK (1) | SK10382002A3 (sh) |
TW (1) | TWI240718B (sh) |
WO (1) | WO2001053256A1 (sh) |
YU (1) | YU52202A (sh) |
ZA (1) | ZA200205696B (sh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10204989A1 (de) * | 2002-02-07 | 2003-08-21 | Aventis Pharma Gmbh | Dihydro-thia-phenanthren-carbonyl-guanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
US20050124666A1 (en) | 2003-11-13 | 2005-06-09 | Aventis Pharma Deutschland Gmbh | Pentafluorosulfanylbenzoylguanidines, process for their preparation, use as a medicament or diagnostic aid, and medicament comprising same |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0556673T3 (da) * | 1992-02-15 | 1998-04-14 | Hoechst Ag | o-Substituerede benzoylguanidiner til behandling og profylakse af hjerterytmeforstyrrelser og iskæmisk inducerede skader samt til inhiberering af celleproliferation |
JP2689058B2 (ja) * | 1992-11-02 | 1997-12-10 | 新日本製鐵株式会社 | 塗装体の乾燥・焼付装置 |
DE4325822A1 (de) | 1993-07-31 | 1995-02-02 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4328869A1 (de) * | 1993-08-27 | 1995-03-02 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE4430916A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Alkyl-benzoylguanidin-Derivate |
DE4430861A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Heterocyclyl-benzoylguanidine |
DE19529612A1 (de) | 1995-08-11 | 1997-02-13 | Merck Patent Gmbh | Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate |
DE19608161A1 (de) * | 1996-03-04 | 1997-09-11 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19621319A1 (de) * | 1996-05-28 | 1997-12-04 | Hoechst Ag | Bis-ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
DE19624178A1 (de) | 1996-06-18 | 1998-01-08 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
2000
- 2000-01-19 DE DE10001879A patent/DE10001879A1/de not_active Withdrawn
-
2001
- 2001-01-08 EP EP01900139A patent/EP1259481B1/de not_active Expired - Lifetime
- 2001-01-08 RU RU2002122089/04A patent/RU2267486C2/ru not_active IP Right Cessation
- 2001-01-08 MX MXPA02006431A patent/MXPA02006431A/es active IP Right Grant
- 2001-01-08 CA CA002397531A patent/CA2397531A1/en not_active Abandoned
- 2001-01-08 CZ CZ20022465A patent/CZ20022465A3/cs unknown
- 2001-01-08 JP JP2001553261A patent/JP4880849B2/ja not_active Expired - Fee Related
- 2001-01-08 KR KR1020027009256A patent/KR100726701B1/ko not_active IP Right Cessation
- 2001-01-08 CN CNB018038247A patent/CN1184196C/zh not_active Expired - Fee Related
- 2001-01-08 BR BR0107660-4A patent/BR0107660A/pt not_active IP Right Cessation
- 2001-01-08 IL IL15074001A patent/IL150740A0/xx unknown
- 2001-01-08 NZ NZ520213A patent/NZ520213A/en unknown
- 2001-01-08 HU HU0204095A patent/HUP0204095A3/hu unknown
- 2001-01-08 PL PL01356589A patent/PL356589A1/xx not_active Application Discontinuation
- 2001-01-08 AU AU23732/01A patent/AU780466B2/en not_active Ceased
- 2001-01-08 AT AT01900139T patent/ATE530518T1/de active
- 2001-01-08 EE EEP200200381A patent/EE200200381A/xx unknown
- 2001-01-08 WO PCT/EP2001/000137 patent/WO2001053256A1/de active IP Right Grant
- 2001-01-08 YU YU52202A patent/YU52202A/sh unknown
- 2001-01-08 SK SK1038-2002A patent/SK10382002A3/sk not_active Application Discontinuation
- 2001-01-17 TW TW090100987A patent/TWI240718B/zh not_active IP Right Cessation
- 2001-01-17 US US09/760,670 patent/US6703411B2/en not_active Expired - Fee Related
- 2001-01-17 AR ARP010100207A patent/AR027237A1/es unknown
-
2002
- 2002-07-12 NO NO20023383A patent/NO20023383L/no not_active Application Discontinuation
- 2002-07-16 HR HR20020592A patent/HRP20020592A2/hr not_active Application Discontinuation
- 2002-07-17 ZA ZA200205696A patent/ZA200205696B/xx unknown
-
2003
- 2003-06-11 HK HK03104145A patent/HK1051853A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200504067A (en) | New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions | |
WO2005037860A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
EP2311851A3 (en) | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | |
ECSP045378A (es) | Derivados novedosos de diazabiciclononeno | |
WO1997046231B1 (en) | Oxa acids and related compounds for treating skin conditions | |
RS105904A (en) | Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament | |
WO2003004472A8 (en) | Arylamines for the treatment of conditions associated with gsk-3 | |
CA2238859A1 (en) | Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them | |
WO2013158824A3 (en) | Cosmetic compositions comprising an alkylene oxide derivative and a n-acyl amino acid compound | |
CA2395541A1 (en) | New substituted piperidines, pharmaceutical compositions containing these compounds and processes for preparing them | |
WO2004082581A3 (fr) | Application a titre de medicaments de derives de cholest-4-en-3- one, compositions pharmaceutiques les renfermant et nouveaux derives | |
TW200637861A (en) | Novel diazabicyclononene derivative | |
RS104804A (en) | N-((3-oxo 2,3-dihydro-1h-isoindol- 1yl)acetyl)guanidine derivatives as nhe-1 inhibitors for the treatment of infarction and angina pectoris | |
NO934634L (no) | 3,5-substiturete aminobenzoylguanidiner, fremgangsmåte til fremstilling derav, deres anvendelse som medikament eller diagnostikum samt middel inneholdende forbindelsene | |
RS99004A (en) | Pentafluorosulfanyl- benzoylguanidine, method for the production thereof and its tilization as medicament or diagnostic agent and medicament containing same | |
DE60045033D1 (de) | Substituierte aromatische ringverbindungen, verfahren zu ihrer herstellung und ihre anwendung | |
RU2003134629A (ru) | Соединения цефема | |
YU52202A (sh) | Supstituisani benzoil-gvanidini, postupak za njihovu proizvodnju, njihova primena kao leka ili kao dijagnostičkog reagensa i medikament koji sadrži ova jedinjenja | |
MY143576A (en) | Chiral derivatives of 3-phenyl-propionic acid, particularly useful for the treatment of diseases associated with ppar-alpha or ppar-gamma | |
CA2295483A1 (en) | Aliphatic propargylamines as cellular rescue agents | |
TW200608967A (en) | Pharmaceutical compositions containing with diabetic agent | |
WO2004007478A3 (en) | Derivatives of 3-guanidinocarbonyl-1-heteroaryl-pyrrole, process for their preparation and their pharmaceutical use | |
IL110625A0 (en) | Urea-substituted benzoylguanidines, process for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical compositions containing them | |
MX2007006745A (es) | Nuevo derivado de diazabiciclononeno. | |
CA2635359A1 (en) | Compositions and methods for synthesizing heterocyclic therapeutic compounds |